Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. - Wikidata - awgldk - TriplyDB

Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.

Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.

http://www.wikidata.org/entity/Q35672517

about

Stem cells in genetically-engineered mouse models of prostate cancer The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung Cellular Plasticity in Prostate Cancer Bone Metastasis Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.Prostate cancer cell lines under hypoxia exhibit greater stem-like properties.Cell-to-cell signaling influences the fate of prostate cancer stem cells and their potential to generate more aggressive tumors.Targeting the osteosarcoma cancer stem cell Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt The role of epithelial plasticity in prostate cancer dissemination and treatment resistance Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.Hypoxia, stem cells and bone tumor The crossroads between cancer stem cells and aging.Stem cell pathologies and neurological disease Induced pluripotent stem cell-related genes influence biological behavior and 5-fluorouracil sensitivity of colorectal cancer cells.Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.Modulation of the tumor vasculature and oxygenation to improve therapy Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer.Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells.Role of SOX2 in the etiology of embryonal carcinoma, based on analysis of the NCCIT and NT2 cell lines.Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers.Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer.E-cadherin plasticity in prostate cancer stem cell invasion E-Cadherin repression increases amount of cancer stem cells in human A549 lung adenocarcinoma and stimulates tumor growth.Polymeric Micelles of PEG-PLA Copolymer as a Carrier for Salinomycin Against Gemcitabine-Resistant Pancreatic Cancer.Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression.The overexpression of SOX2 affects the migration of human teratocarcinoma cell line NT2/D1.Elimination of cancer stem-like side population in human glioblastoma cells accompanied with stemness gene suppression by Korean herbal recipe MSC500.Overexpression of SOX2 promotes migration, invasion, and epithelial-mesenchymal transition through the Wnt/β-catenin pathway in laryngeal cancer Hep-2 cells.Prognostication of OCT4 isoform expression in prostate cancer.Blocking mtDNA replication upregulates the expression of stemness-related genes in prostate cancer cell lines.

P2860

Q26784057-2D5D9E2D-5A2C-4D4C-8342-8B6B289C67D7 Q26822879-2E1BF8DC-EDFB-4A8B-A7F7-8C4C431389F0 Q28085013-2752BCD2-2BFB-4E9E-8BAC-223C9B9847EB Q31049380-1B0D96FD-5287-4C31-B4FA-AC13112408A8 Q34105402-98968340-41A0-402B-A22A-C00A69876740 Q34117287-11E087B9-9F2A-41D3-8722-4143B1659DDC Q34157307-6FAC3F14-1DB0-49E1-933E-EE8F830126D6 Q34335524-63CD1D89-CAF0-4595-A193-D047F2735028 Q34473795-66E950A1-D0CC-4A1F-B545-879DC40AE9F3 Q34486971-EE8F564D-DE00-48BF-8740-AB0160E9B773 Q34505037-DBE6AB7B-E2EF-453D-86E3-649381D5950C Q34654576-D238F7DD-D6B7-4AB8-9498-F2BBF34E3B61 Q34798746-4E39A9FB-C750-4B03-B84C-1C27ED8DE7DE Q35049178-D3FDB0EF-A904-4DFB-94BC-5BA7655489B2 Q35287094-CFD74728-4AF5-4002-9555-BEEA0762C3B0 Q35549238-B468226D-01A8-4EA3-9F5D-FF6A0972FEDF Q35566484-FE8F3A46-BBEB-4E13-89D6-E4ECE11ABBAE Q35626316-65FF8B6D-D9A2-4EC3-B7B3-727957F2C358 Q35653328-44E9CB7C-1BC7-4BBE-9349-16E1CCC24073 Q35746535-264A3A18-7DF7-4D8A-A8A9-EAD8BA4CCB65 Q35920685-5125DF21-924F-4D74-8654-EC9F83FF11CC Q36144913-666076D3-AE5F-413B-8142-AD08A88E0AFD Q36232040-467733EE-BACB-471A-8A35-FFA315155651 Q36344857-E36C2975-5A7C-4921-92DC-E66FD9EB6509 Q36407948-D2AD36F0-76AF-48F8-85AF-EB0EDE81AEDE Q36643062-2A269271-4FBC-4CC4-86A9-63B283AEC7A9 Q37431340-797F2FCC-4AEA-40A9-ACAC-39BE01688417 Q37706613-DC707BEA-A39B-4C4C-B255-E8113A1791EE Q37794511-D4752EF2-A459-4D16-BF3F-A44A0CCDD1D7 Q38180344-A3F6ECE5-B237-4AD7-A4ED-4656BA221570 Q38336985-510861D0-17B1-40C7-8570-B6A2424FD19E Q38561949-4058352B-7D6F-4A75-8692-407A76B551E1 Q38789106-F3F93B60-6C87-4C21-A274-2A5E3CF04A1C Q38847679-E1CEA68E-2B66-4154-A759-921846BF2D5E Q38878117-CF82A821-37C7-4A5D-8FAC-E26BE4E6F849 Q38901084-D5ED9476-91AA-453A-B90C-3EE8B1FC8B5E Q38943613-8D26D5A0-208B-462A-BF2D-F976D546048E Q38994534-E5DD1E93-D2ED-4EB1-87A2-8E7E6A553151 Q39157588-2F1A76C3-9ED0-4547-BCFD-3D8D36491D60 Q39157835-D6BA9154-DBEB-4031-A6CB-FB98514BAB93

P2860

Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.

http://www.wikidata.org/entity/Q35672517

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Expression of pluripotent stem ...... ostate tumor initiating cells.

@ast

Expression of pluripotent stem ...... ostate tumor initiating cells.

@en

type

label

Expression of pluripotent stem ...... ostate tumor initiating cells.

@ast

Expression of pluripotent stem ...... ostate tumor initiating cells.

@en

prefLabel

Expression of pluripotent stem ...... ostate tumor initiating cells.

@ast

Expression of pluripotent stem ...... ostate tumor initiating cells.

@en

P1433

Q35672517-9A436FCB-BDD3-4757-AA99-7064682C7FD9

P1476

Q35672517-DE499854-1BAA-4A01-AF4B-D12EBA79E86F

P2093

Q35672517-10893EC3-2782-4BC4-B347-0AF953F20939

Q35672517-34C8112A-F92E-4190-A3FE-5DB9F2AA57C2

Q35672517-4DEE29B6-18CB-45E2-B906-E7B3C5F5BEC5

Q35672517-6E99FCB5-6908-4A26-A389-DC40351C4953

Q35672517-86BF8D41-C341-42AD-BDA2-A0DA6298F492

Q35672517-8B144513-3964-4ED0-B427-19F31C4823BB

Q35672517-A2A3C84C-6306-437F-B143-1240C9D149D9

Q35672517-AE33CED9-F263-4F18-8546-8B816D33E6C1

Q35672517-C1600685-3191-4FF9-87EF-AD971762AB6C

Q35672517-F37DA732-DDD6-4DBD-BE97-5627261DE984

P2860

Q35672517-03ED3289-13A6-4D0B-92A4-0EB5516AB0B1

Q35672517-08BEC8AC-06F2-4BF1-AE89-21F109F666EB

Q35672517-18D1A02F-60B3-45FC-B42D-FBF886A6B96C

Q35672517-235F6A4C-59EE-4076-AE71-526CB03E685C

Q35672517-2F8B66A8-B476-4479-8C7C-FC0133CE6760

Q35672517-3B85F6F0-B273-4C86-B1CC-4F279576CD15

Q35672517-3D8FDEF5-99D3-4241-B23A-80764A158417

Q35672517-4D39ECB1-72C3-4297-A89C-9F0B5E820B35

Q35672517-4F5F3402-5DCC-43F4-9B6A-E19FA1BE8B4D

Q35672517-55A9FEBE-3E88-4DFB-9D31-FA6A9AEFC99F

P304

Q35672517-12948551-71B9-4FAF-8745-57AE975689D3

P31

Q35672517-618AFB10-053B-4FBC-BCC0-44FB4EE3B8DC

P356

Q35672517-D597CC76-741E-49CA-9CED-7103915B8973

P407

Q35672517-11FEB2E9-02E1-48BE-AA97-B3339837E929

P433

Q35672517-78509912-DEFB-4E45-B9E3-2CB303E8B43E

P478

Q35672517-449257CE-1557-43FA-BF88-6DDCB734D8F4

P577

Q35672517-42938078-6E78-44EE-8722-BF0D0D5584C7

P5875

Q35672517-74EECDB0-E884-4E23-A7A3-45722F8BF603

P698

Q35672517-2AAC3001-A0BE-488D-992D-664389B3FCA5

P932

Q35672517-791E2036-8666-4791-9B94-2ACAEDA4789C

P356

J.JURO.2009.12.092

P1433

The Journal of Urology

P1476

Expression of pluripotent stem ...... ostate tumor initiating cells.

@en

P2093

Carole Frye

http://www.w3.org/2001/XMLSchema#string

Dennis A Steindler

http://www.w3.org/2001/XMLSchema#string

Dietmar W Siemann

http://www.w3.org/2001/XMLSchema#string

Johannes Vieweg

http://www.w3.org/2001/XMLSchema#string

Joseph T Andrejewski

http://www.w3.org/2001/XMLSchema#string

Kyung-Mi Bae

http://www.w3.org/2001/XMLSchema#string

Marda Jorgensen

http://www.w3.org/2001/XMLSchema#string

Robert W Allan

http://www.w3.org/2001/XMLSchema#string

Steve McClellan

http://www.w3.org/2001/XMLSchema#string

Vicky Kelley

http://www.w3.org/2001/XMLSchema#string

P2860

The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations

Cancer statistics, 2008

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures

Prospective identification of tumorigenic prostate cancer stem cells

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

Epigenetic stem cell signature in cancer

Anchorage-independent culture maintains prostate stem cells.

Pten, tumorigenesis, and stem cell self-renewal.

P304

2045-2053

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2009.12.092

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

183

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42370491

http://www.w3.org/2001/XMLSchema#string

P698

20303530

http://www.w3.org/2001/XMLSchema#string

P932

4451595

http://www.w3.org/2001/XMLSchema#string